Desenvolvimento e validação de método analítico para determinação de brinzolamida em suspensão oftálmica 1%
View/ Open
Date
2011Advisor
Co-advisor
Academic level
Graduation
Subject
Abstract
Glaucoma is an optic neuropathy caused by multiple factors, characterized by progressive damage to the optic nerve and increased intraocular pressure, its main risk factor. Brinzolamide is a sulfonamide nonbacteriostatic derivative inhibitor of carbonic anhydrase II, which decreases the intraocular pressure by reducing aqueous humor formation. A stability-indicating HPLC method for the determination of brinzolamide in ophthalmic solution was developed and validated. Chromatographic analysis wer ...
Glaucoma is an optic neuropathy caused by multiple factors, characterized by progressive damage to the optic nerve and increased intraocular pressure, its main risk factor. Brinzolamide is a sulfonamide nonbacteriostatic derivative inhibitor of carbonic anhydrase II, which decreases the intraocular pressure by reducing aqueous humor formation. A stability-indicating HPLC method for the determination of brinzolamide in ophthalmic solution was developed and validated. Chromatographic analysis were performed in Phemomenex® C18 column (150x4.6 mm, particle size 5 μm). The mobile phase was composed of acetonitrile and 25 mM monobasic potassium phosphate buffer adjusted to pH 5.8 (40:60; v/v), flow rate of 1.0 mL/min and injection volume of 20 μL. The method was simple, rapid, specific, linear, precise, accurate and robust, suitable for use in routine quality control. ...
Institution
Universidade Federal do Rio Grande do Sul. Faculdade de Farmácia. Curso de Farmácia.
Collections
This item is licensed under a Creative Commons License